Varaico: Literature-Extracted Genetic Variants

Gene:GALNT3
Variant:p.R162*
Back to variants list

GALNT3

NM_004482.4:p.R162*

Associated Papers

Germline predisposition in multiple myeloma.

Martins Rodrigues F et al.

Iscience, 2025

39845416 (PubMed )
Supplement: mmc3.xlsx › ST2D.Vars_in_all_genes_MMRF

Pathogenic variation underlying rare diseases in an Arab population: Implications for screening programs.

Jain R et al.

Genetics in Medicine Open, 2025

40893834 (PubMed )
Supplement: mmc1.xlsx › Supplementary_Table_3

A GALNT3 mutation causing Hyperphosphatemic familial Tumoral calcinosis.

Wu A et al.

Molecular Genetics and Metabolism Reports, 2024

Burden of Mendelian disorders in a large Middle Eastern biobank.

Aamer W et al.

Genome Medicine, 2024

38584274 (PubMed )
Supplement: 13073_2024_1307_MOESM1_ESM.xlsx › Table_S3

Rare and Common Variants in GALNT3 May Affect Bone Mass Independently of Phosphate Metabolism.

Hassan N et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2023

Polypeptide N-acetylgalactosamine transferase 3: a post-translational writer on human health.

Garay YC et al.

Journal of Molecular Medicine (berlin, Germany), 2022

The QChip1 knowledgebase and microarray for precision medicine in Qatar.

Rodriguez-Flores JL et al.

Npj Genomic Medicine, 2022

High-depth African genomes inform human migration and health.

Choudhury A et al.

Nature, 2020

33116287 (PubMed )
Supplement: 41586_2020_2859_MOESM3_ESM.xlsx › Supp_T19

Hyperphosphatemic familial tumoral calcinosis caused by a novel variant in the GALNT3 gene.

Mahjoubi F et al.

Journal of Endocrinological Investigation, 2020

The GenomeAsia 100K Project enables genetic discoveries across Asia.

Unknown Author

Nature, 2019

31802016 (PubMed )
Supplement: 41586_2019_1793_MOESM3_ESM.xlsx › S4b_-_Disease_Var

Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis.

Albaramki J et al.

The Turkish Journal of Pediatrics, 2019

Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.

Torrezan GT et al.

Frontiers in Genetics, 2018

29868112 (PubMed )
Supplement: Table_1.DOCX

Identification of two novel mutations in the GALNT3 gene in a Chinese family with hyperphosphatemic familial tumoral calcinosis.

Sun L et al.

Bone Research, 2016

Root anomalies and dentin dysplasia in autosomal recessive hyperphosphatemic familial tumoral calcinosis (HFTC).

Vieira AR et al.

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2015

GALNT3 gene mutation-associated chronic recurrent multifocal osteomyelitis and familial hyperphosphatemic familial tumoral calcinosis.

Demellawy DE et al.

Scandinavian Journal of Rheumatology, 2015

Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature.

Rafaelsen S et al.

Bmc Genetics, 2014

A mouse with an N-Ethyl-N-nitrosourea (ENU) Induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis.

Esapa CT et al.

Plos One, 2012

Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Farrow EG et al.

Best Practice & Research. Clinical Rheumatology, 2011

Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis.

Yancovitch A et al.

Journal of Bone and Mineral Metabolism, 2011

Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations.

Ichikawa S et al.

American Journal of Medical Genetics. Part A, 2010

Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.

Chefetz I et al.

Biochimica Et Biophysica Acta, 2009

Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome.

Gok F et al.

Acta Orthopaedica, 2009

Two novel GALNT3 mutations in familial tumoral calcinosis.

Garringer HJ et al.

American Journal of Medical Genetics. Part A, 2007

A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.

Ichikawa S et al.

The Journal of Clinical Endocrinology and Metabolism, 2005

Mutations in SEC63 cause autosomal dominant polycystic liver disease.

Davila S et al.

Nature Genetics, 2004

Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.

Topaz O et al.

Nature Genetics, 2004

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."